175137-54-9

Basic information

• Product Name: ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE
• Synonyms: AKOS B020545;AKOS PAO-0926;ART-CHEM-BB B020545;BUTTPARK 47\04-33;ETHYL 4-BROMO-3,5-DIMETHYLPYRAZOL-1-YL ACETATE;ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE;Ethyl 2-(4-bromo-3,5-dimethyl-1H-pyrazol-1-;Ethyl [4-bromo-3,5-dimethyl-1H-pyrazol-1-yl]acetate
• CAS NO: 175137-54-9
• Molecular Formula: C9H13BrN2O2
• Molecular Weight: 261.12
• Mol File: 175137-54-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 319.6 °C at 760 mmHg
• Flash Point: 147.1 °C
• Appearance: /
• Density: 1.46
• Vapor Pressure: 0.000336mmHg at 25°C
• Refractive Index: 1.561
• CAS DataBase Reference: ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE(175137-54-9)
• EPA Substance Registry System: ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE(175137-54-9)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 175137-54-9(Hazardous Substances Data)

Usage

General Description

ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE is a chemical compound with the molecular formula C10H14BrNO2. It is a pyrazole derivative that contains a bromine atom and two methyl groups attached to the pyrazole ring. ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various biologically active molecules. It is also used as an intermediate in the production of agricultural chemicals, pharmaceuticals, and other organic compounds.ETHYL 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETATE may have potential applications in the development of new drugs and other medical treatments.

InChI:InChI=1/C9H13BrN2O2/c1-4-14-8(13)5-12-7(3)9(10)6(2)11-12/h4-5H2,1-3H3

Upstream product

• 3398-16-1 4-Bromo-3,5-dimethylpyrazole 
• 105-36-2 ethyl bromoacetate 

Relevant articles and documents

NOVEL HETEROARYL COMPOUND, ENANTIOMER, DIASTEREOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND ANTIVIRAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT

The present invention relates to a novel heteroaryl compound, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof, and an antiviral composition comprising the same as an active ingredient. The novel compounds represented by formula (I) or formula (II) according to the present invention are remarkably superior in antiviral activity against an influenza virus, and furthermore, have low cytotoxicity and thus low adverse effects on a human body. Therefore, a pharmaceutical composition containing the same as an active ingredient can be effectively used for the prevention or treatment of diseases caused by an influenza virus infection.

DGAT1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF

The present invention discloses a novel DGAT1 inhibitor, especially the compound of formula (I) or a pharmaceutically acceptable salt thereof, preparation and pharmaceutical composition thereof, as well as their uses in the preparation of a medicament for the prevention and treatment of Familial hyperchylomicronemia (FCS), obesity, hyperlipoproteinemia or hypertriglyceridemia.